Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Operating Expenses: 2015-2025

Historic Operating Expenses for Wave Life Sciences (WVE) over the last 11 years, with Sep 2025 value amounting to $64.0 million.

  • Wave Life Sciences' Operating Expenses rose 13.73% to $64.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $245.2 million, marking a year-over-year increase of 19.21%. This contributed to the annual value of $218.7 million for FY2024, which is 20.63% up from last year.
  • Per Wave Life Sciences' latest filing, its Operating Expenses stood at $64.0 million for Q3 2025, which was up 4.07% from $61.5 million recorded in Q2 2025.
  • In the past 5 years, Wave Life Sciences' Operating Expenses registered a high of $64.0 million during Q3 2025, and its lowest value of $37.9 million during Q4 2021.
  • Moreover, its 3-year median value for Operating Expenses was $54.7 million (2024), whereas its average is $53.1 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first decreased by 19.73% in 2021, then rose by 27.32% in 2024.
  • Quarterly analysis of 5 years shows Wave Life Sciences' Operating Expenses stood at $37.9 million in 2021, then grew by 18.29% to $44.8 million in 2022, then rose by 6.55% to $47.7 million in 2023, then rose by 27.32% to $60.8 million in 2024, then grew by 13.73% to $64.0 million in 2025.
  • Its Operating Expenses was $64.0 million in Q3 2025, compared to $61.5 million in Q2 2025 and $59.0 million in Q1 2025.